Skip Surgery for DCIS in Favor of Active Monitoring?

(MedPage Today) -- SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET trial showed.
The 2-year...